Ruixun Bio

Ruixun Bio (锐讯生物) is a digital PCR company and a ZhenFund angel portfolio project focused on life science and clinical diagnostic tools . Its RS32 series offers a fully integrated digital PCR workflow with up to 7-color fluorescence channels and 32-sample throughput, which was already being sold and installed overseas by early 2025, with the company describing itself as leading among domestic brands for overseas all-in-one machine installations . The company has pursued an international strategy: it showcased its DropDx-2044HT digital PCR system at Thailand Lab International 2024 in Bangkok , appeared at Medlab Middle East 2025 in Dubai , and reported sales in over 30 countries and regions . In late 2024, Ruixun Bio completed a C2 strategic funding round of tens of millions of RMB, led by Ruijiang Kangcheng, with proceeds earmarked for domestic and international clinical registration of its digital PCR products .